FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3183031612> ?p ?o ?g. }

• W3183031612 abstract "Abstract Background Deciding on pharmaceutical subsidy is regarded as a challenging issue for healthcare policymakers in Iran in most times. Public preferences, rarely attended in Iran, could be invaluable for including a particular drug in the list of subsidized medications. Objectives The current study aims to elicit the public preferences to develop an evidence-based decision-making framework for entering a drug into the list of subsidies in Iran. Methods Discrete Choice Experiment (DCE) was employed to elicit the public preferences. Around 34 attributes were identified based on the systematic review and interview with 51 experts. By holding an expert panel, 7 attributes were finalized, namely: the survival after treatment, quality of life after treatment (QoL), alternative treatment, age group of the target population, cost burden for the government, disease severity, and drug manufacturer country. Next, 1224 households were selected for the survey in the city of Tehran, using random cluster sampling. Data were analyzed using conditional logit model. Results The survival after treatment ( β = 1.245; SE = 0.053) and cost burden for the government ( β = − 0.140; SE = 0.050) had the highest and lowest priority, respectively, in the preferences for allocating subsidy to a drug. In developed region, unlike the other two regions, the level of domestic drug production ( β =− 0.302; SE = 0.073) was inversely associated with preferences toward allocating subsidy to a drug. In contrast to other districts, those living in district number one ( β = 2.053; SE = 0.138) gave the highest value to promoting the QoL after treatment. Conclusions It is suggested that policymakers pay more attention to attributes such as effectiveness and alternative treatment when developing an evidence-based framework for entering a drug into the list of subsidies. This study highlighted the public belief in the government’s subsidy for medicines, provided that, this results in an increased survival and QoL." @default.
• W3183031612 created "2021-07-19" @default.
• W3183031612 creator A5001260080 @default.
• W3183031612 creator A5013136925 @default.
• W3183031612 creator A5034356026 @default.
• W3183031612 creator A5052186158 @default.
• W3183031612 creator A5069287180 @default.
• W3183031612 creator A5083563734 @default.
• W3183031612 date "2021-07-13" @default.
• W3183031612 modified "2023-09-27" @default.
• W3183031612 title "Eliciting the public preferences for pharmaceutical subsidy in Iran: a discrete choice experiment study" @default.
• W3183031612 cites W1574332462 @default.
• W3183031612 cites W1590210216 @default.
• W3183031612 cites W1593602309 @default.
• W3183031612 cites W1959331022 @default.
• W3183031612 cites W1975941913 @default.
• W3183031612 cites W1983185109 @default.
• W3183031612 cites W1987521899 @default.
• W3183031612 cites W1992928808 @default.
• W3183031612 cites W1995389962 @default.
• W3183031612 cites W2003949079 @default.
• W3183031612 cites W2005518535 @default.
• W3183031612 cites W2008612782 @default.
• W3183031612 cites W2027504015 @default.
• W3183031612 cites W2034779927 @default.
• W3183031612 cites W2038273794 @default.
• W3183031612 cites W2049732187 @default.
• W3183031612 cites W2066910314 @default.
• W3183031612 cites W2075157604 @default.
• W3183031612 cites W2079103070 @default.
• W3183031612 cites W2084906650 @default.
• W3183031612 cites W2085909292 @default.
• W3183031612 cites W2092828798 @default.
• W3183031612 cites W2121619367 @default.
• W3183031612 cites W2121722424 @default.
• W3183031612 cites W2123272213 @default.
• W3183031612 cites W2127227735 @default.
• W3183031612 cites W2139213716 @default.
• W3183031612 cites W2139381885 @default.
• W3183031612 cites W2141572885 @default.
• W3183031612 cites W2154293556 @default.
• W3183031612 cites W2161458058 @default.
• W3183031612 cites W2166428722 @default.
• W3183031612 cites W2168828963 @default.
• W3183031612 cites W2170717785 @default.
• W3183031612 cites W2192871920 @default.
• W3183031612 cites W2237448084 @default.
• W3183031612 cites W2258180729 @default.
• W3183031612 cites W2282290958 @default.
• W3183031612 cites W2367707061 @default.
• W3183031612 cites W2491354712 @default.
• W3183031612 cites W2566417860 @default.
• W3183031612 cites W2593276100 @default.
• W3183031612 cites W2610703029 @default.
• W3183031612 cites W2618933986 @default.
• W3183031612 cites W2733328613 @default.
• W3183031612 cites W2742841127 @default.
• W3183031612 cites W2759932401 @default.
• W3183031612 cites W2810916957 @default.
• W3183031612 cites W2997125344 @default.
• W3183031612 cites W3041782397 @default.
• W3183031612 cites W3122068553 @default.
• W3183031612 cites W3124377353 @default.
• W3183031612 cites W4200330985 @default.
• W3183031612 doi "https://doi.org/10.1186/s40545-021-00345-4" @default.
• W3183031612 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8278681" @default.
• W3183031612 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34256875" @default.
• W3183031612 hasPublicationYear "2021" @default.
• W3183031612 type Work @default.
• W3183031612 sameAs 3183031612 @default.
• W3183031612 citedByCount "2" @default.
• W3183031612 countsByYear W31830316122021 @default.
• W3183031612 countsByYear W31830316122022 @default.
• W3183031612 crossrefType "journal-article" @default.
• W3183031612 hasAuthorship W3183031612A5001260080 @default.
• W3183031612 hasAuthorship W3183031612A5013136925 @default.
• W3183031612 hasAuthorship W3183031612A5034356026 @default.
• W3183031612 hasAuthorship W3183031612A5052186158 @default.
• W3183031612 hasAuthorship W3183031612A5069287180 @default.
• W3183031612 hasAuthorship W3183031612A5083563734 @default.
• W3183031612 hasBestOaLocation W31830316121 @default.
• W3183031612 hasConcept C100001284 @default.
• W3183031612 hasConcept C138816342 @default.
• W3183031612 hasConcept C138885662 @default.
• W3183031612 hasConcept C144133560 @default.
• W3183031612 hasConcept C149782125 @default.
• W3183031612 hasConcept C159110408 @default.
• W3183031612 hasConcept C162324750 @default.
• W3183031612 hasConcept C190669063 @default.
• W3183031612 hasConcept C2778137410 @default.
• W3183031612 hasConcept C2908647359 @default.
• W3183031612 hasConcept C34447519 @default.
• W3183031612 hasConcept C41895202 @default.
• W3183031612 hasConcept C71924100 @default.
• W3183031612 hasConcept C84265765 @default.
• W3183031612 hasConcept C99454951 @default.
• W3183031612 hasConceptScore W3183031612C100001284 @default.
• W3183031612 hasConceptScore W3183031612C138816342 @default.
• W3183031612 hasConceptScore W3183031612C138885662 @default.
• W3183031612 hasConceptScore W3183031612C144133560 @default.

• next